NYSE Group Consolidated Short Interest Report
NYSE Group Consolidated Short Interest Report
NYSE today reported short interest as of the close of business on the settlement date of September 13, 2024.
SETTLEMENT DATE |
EXCHANGE |
TOTAL CURRENT
|
TOTAL PREVIOUS
|
NUMBER of
|
NUMBER of
|
09/13/2024 |
NYSE |
13,905,190,366 |
13,547,419,694 |
2,908 |
2,626 |
09/13/2024 |
NYSE Arca |
1,759,627,828 |
1,748,872,917 |
2,165 |
1,362 |
09/13/2024 |
NYSE American |
667,854,068 |
667,345,216 |
324 |
260 |
09/13/2024 |
NYSE Group |
16,332,672,262 |
15,963,637,827 |
5,397 |
4,248 |
*NYSE Group includes NYSE, NYSE American and NYSE Arca |
|
|
|
|
|
Reports will be archived here.
Media Contact:
NYSE Communications
PublicRelations-NYSE@ice.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240924579201/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks